Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Samwel Mikaye: Understanding Warfarin and Its Clinical Management
Nov 16, 2026, 12:26

Samwel Mikaye: Understanding Warfarin and Its Clinical Management

Samwel Mikaye, Medical Doctor at MSK, shared a post on LinkedIn:

”Warfarin

Warfarin is an oral anticoagulant used to prevent and treat blood clots.

It is a vitamin K antagonist (VKA).

Mechanism of Action

Warfarin inhibits vitamin K epoxide reductase, reducing the synthesis of vitamin K–dependent clotting factors:

  • Factor II (Prothrombin)
  • Factor VII
  • Factor IX
  • Factor X
  • Proteins C and S

This reduces the blood’s ability to form clots.

Common Indications

  • Atrial fibrillation – prevention of stroke
  • Deep vein thrombosis (DVT)
  • Pulmonary embolism (PE)
  • Mechanical heart valves
  • Selected hypercoagulable disorders

Monitoring

Warfarin therapy is monitored using the International Normalized Ratio (INR).

Typical target INR:

  • Most indications: 2.0–3.0
  • Some mechanical heart valves: 2.5–3.5, depending on valve type and location

Important Adverse Effects

  •  Bleeding – the most important complication
  • Easy bruising
  • Gastrointestinal or intracranial bleeding
  • Warfarin-induced skin necrosis (rare)
  • Teratogenicity – generally avoided during pregnancy

Drug and Food Interactions

Warfarin has numerous interactions.

Foods high in vitamin K may reduce its anticoagulant effect. Examples include green leafy vegetables. Patients do not necessarily need to avoid them, but should maintain a consistent dietary intake.

Several drugs can increase or decrease INR, including some:

  • Antibiotics
  • Antifungals
  • Anti-inflammatory drugs
  • Antiepileptic medications

Reversal of Warfarin

For significant bleeding or urgent reversal:

  • Vitamin K
  • 4-factor prothrombin complex concentrate (4F-PCC) is generally used for rapid reversal when indicated.

Key Clinical Pearl

A high INR increases bleeding risk, but clinical management depends on the INR, presence of bleeding, indication for anticoagulation, and patient-specific factors.

In summary: Warfarin is an effective anticoagulant but requires regular INR monitoring, attention to drug interactions, and careful bleeding-risk assessment.

Would you like a simple patient-friendly summary or a detailed warfarin dosing and INR management guide for clinicians?

Important: Never advise a patient to stop, start, or change warfarin dosage without appropriate clinical review and INR results. If there is major bleeding, severe headache, vomiting blood, black stools, or sudden weakness, urgent medical assessment is needed.”

Samwel Mikaye: Understanding Warfarin and Its Clinical Management

Other posts featuring Samwel Mikaye on Hemostasis Today.